SPEAKERS

Camille Campbell, PharmD, RPh (formerly Camille Pope) is the Senior Director of Health Equity and former Chief Medical Lead at Acclinate. Acclinate leverages community engagement and trust-enabling technology to empower communities to take actions for better health and improve representation in...

25 years of bioengineering, innovation development, regulatory and clinical affairs, product launch, VC and executive experience.

Dr. Abramsohn brings 20 years of public service to IDPN, including 15 years with the Centers for Disease Control and Prevention. Her work has focused on catalyzing collaborations between public health and health care and has impacted critical public health priorities, including protecting the...

Dr. Karen Acker is an Assistant Professor in Clinical Pediatrics at Weill Cornell Medicine and Pediatric Hospital Epidemiologist at NYP/ Komansky Children’s Hospital. After completing her fellowship in pediatric infectious diseases at Columbia University Medical Center in 2018, she joined the...

Sarah is a motivated research and development coordinator with a background in molecular biology and infectious diseases. During her undergraduate years, Sarah was the recipient of nationally recognized research awards including the Barry Goldwater scholarship and the IDeA Networks of Biomedical...

Jenn Alton is President of Pathway Policy Group, a health policy consulting firm. She is an expert in policy structuring and public health advocacy, with over two decades of experience in senior corporate and federal government roles. Jenn advises senior leaders in the private, non-profit and...

Dr. Angelidou is a Board-certified Neonatologist at Beth Israel Deaconess Medical Center (Boston, MA), Principal Investigator and Clinical Lead at the Precision Vaccines Program (PVP) in Boston Children’s Hospital, and Assistant Professor in Pediatrics at Harvard Medical School. She obtained her...

Jorge Armero Gimenez is a key member of LenioBio’s Platform Development team, specializing in the advancement of recombinant protein vaccines utilizing the ALiCE® cell-free protein expression system.Jorge earned his PhD from Wageningen University & Research (WUR) in collaboration with LenioBio...

Dr. Irnela Bajrovic received her PhD in pharmaceutical sciences from the University of Texas at Austin. Her graduate work established the viability of the thin film technology as a superior method of vaccine stabilization, which bypasses cold-chain maintenance and has the potential to simplify the...

Shweta Bansal is Professor at the Department of Biology at Georgetown University. At Georgetown University, Dr. Bansal leads an interdisciplinary research group that develops data-driven mathematical models for human and animal disease systems using tools from network science, statistical...

Miranda Baxa, MPH (she/her) is a Consultant for Health Policy & Insights at Economist Impact. Miranda provides support for projects related to health equity and health policy. She has successfully led multifaceted research programmes, including Economist Impact’s current work on long covid and...

Jenna Benefield is a leader in McKinsey’s Pharmaceuticals & Medical Products Practice, serving clients across a variety of Strategy and Commercial topics – including revenue growth strategy, asset diligence, and physician/patient engagement. She co-leads the knowledge development for industry...

Georges C. Benjamin, MD, is a well-known health policy leader, practitioner, and administrator. He currently serves as the executive director of the American Public Health Association, the nation's oldest and largest organization of public health professionals. He is also a former secretary of...

A medical doctor and infectious disease epidemiologist, Dr Seth Berkley is currently serving as an advisor and Board member to numerous health and technology companies and is an Adjunct Professor at the Pandemic Center at Brown University.  He previously was CEO of Gavi, the Vaccine Alliance from...

After studying the potential effect of phase variation on long-term asymptomatic colonization of the human nasopharynx by the meningococcus, Dr. Fadil Bidmos obtained a PhD in meningococcal genetics and immunology, with a specific focus on the vaccine candidacy of the phase-variable...

Erwin Blomsma holds a Master’s degree in Bioscience Engineering and a Ph.D. in Applied Biological Sciences (1995) from KU Leuven in Belgium.  After post-doctoral studies at UCB he started his career at Janssen Pharmaceutica in 1996 in the Chemical Process Technology Group.  In 2000 he co-founded...

Dr. Aurelio Bonavia works in Vaccine Development at the Gates Medical Research Institute developing adjuvants/vaccines/monoclonals for Malaria, Shigella, and RSV.  Previously he served as Sr. Director of Clinical Development at Vir Biotechnology where he was the Study Director for VIR-2482 a...

Luigi Bonfatti is Executive Advisor at RVMC (Regionalized Vaccine Manufacturing Collaborative). As member of RVMC Leadership he has global accountability on industry (and industry associations) engagement as well as for Asia regionalization agenda. Before joining RVMC, Luigi has been supporting...

Marie Bonhomme, Ph.D., currently serves as Director of Labs at PPD, part of Thermo Fisher Scientific, where she provides strategic and operational oversight for the Vaccines Sciences Department within the Clinical Research Group. Dr. Bonhomme is known for her expertise in the field of Immunology...

Luciana Borio, M.D., is a Venture Partner at ARCH Venture Partners. In this capacity, she advises on and helps develop new investment opportunities related to biologics manufacturing, clinical trials, novel therapies, and areas with large unmet clinical needs. She is also an adjunct Assistant...

Dr. Maria Elena Bottazzi is an internationally recognized tropical and emerging disease vaccinologist, global health advocate and cocreator of a patent-free, open science COVID-19 vaccine technology that led to the development of Corbevax in India and IndoVac in Indonesia, and with approximately...

Charlotte is the CEO & Founder of Evrima Technologies and has 15 years’ experience in business development, operations, project management, with a passion for patient recruitment. Starting at a Phase 1 unit, then going on to establish Evrima, she led the development and commercialization of...

Michael Breen is a Scientist at Tiba Biotech. He joined Tiba after finishing his Ph.D. in Microbiology at Boston University in 2023 where he studied lung-resident B cell populations that arise after influenza virus infection. At Tiba, Michael has initiated multiple therapeutic and vaccine research...

Dr. Gabrielle Breugelmans is the Director of Epidemiology and Data Science at the Coalition for Epidemic Preparedness Innovations (CEPI). Her department's mission is to support CEPI, its partners, and stakeholders by bridging key epidemiological knowledge gaps critical for vaccine...

Dr. Bridges is a board-certified internal medicine physician who has worked on influenza and adult immunization issues for over 28 years.  She completed medical school at University of Washington, and internal medicine residency at University of Colorado.  After working as a primary care physician...

Dr. Kate Broderick leverages more than 20 years of life science experience with over 15 years in research and development as the head of Maravai’s newly established Science and Innovation Office. A recognized expert in vaccine and nucleic acid technology, Dr. Broderick has led global teams and...

Michelle Brown MD PhD Vice President, Portfolio Lead, Oncology, Moderna     Michelle Brown, MD PhD, obtained her dual degree and post-doctoral training from the University of Utah and Huntsman Cancer Institute with focus on understanding the mechanisms of oncogenesis in pediatric oncology. As a...

Dr. Buck received a bachelor’s degree in Molecular Cellular and Developmental Biology from the University of Colorado at Boulder. He then returned to his home state, Maryland, to earn a Ph.D. from the Johns Hopkins School of Medicine.  Dr. Buck’s graduate research in Dr. Robert Siliciano's lab...

Dr. Amelia Burke-Garcia is a seasoned health communications professional with 20 years of experience in health communication program planning, implementation, and evaluation. At NORC, she leads the organization's Center for Health Communication Science, in which role, she designs and implements ...

  Dr. David Burkhart is the Chief Executive Officer and a Co-Founder of Inimmune, a leading biotech company focused on the discovery and development of next generation vaccines and vaccine adjuvant systems.  Dr. Burkhart was an Investigator with GlaxoSmithKline for 8 years in the...

Andy Burstein, is a co-founder and the CEO of Accessible Pharmacy Services. Accessible Pharmacy Services is a national home delivery pharmacy service and healthcare company specializing in patients with disabilities. They are the only provider of its kind in the world and the largest blind-owned...

Gaurav is scientist, innovator, and entrepreneur, serving as the CEO and Co-Founder of Piezo Therapeutics. Prior to Piezo, he served in a variety of roles at Moelis and Company, Capital One, and Elevance Health. He’s a published scientist with a background in drug delivery and synthetic...

Dr. Tom Campi is the CEO of Modulant Biosciences, an animal health biotechnology company focusing on therapies for infectious and chronic diseases. The current pipeline includes drugs for FIP, a fatal coronavirus in cats; Parvo, a serious enteric disease in dogs, PRRSv, a continuing problem for the ...

As Chief Science Officer and Global Head, External Scientific Affairs for Sanofi Vaccines, Dr. Casimiro is responsible for several external-facing functions of the Vaccines R&D unit, including teams for search-and-evaluation of vaccine candidates and vaccine innovations, scientific network...

Mia is the Director of Business Development at CRIO, an innovative company specializing in eSource technology. In her role, Mia works with sponsors, CROs, and sites to implement and optimize the CRIO solutions to drive greater efficiency in clinical trials. Mia leverages her expertise in technology ...

José is recognized as a serial entrepreneur and prolific innovator in the biopharmaceutical industry. With a strong track record in innovative processes and design to make biotech drugs more affordable and accessible, he played a crucial role in creating the Nevoline platform.

Dr. Cayli is CEO and Chairman of Florabio. Dr. Cayli has started his cell culture venue by Roche Diagnostics in Penzberg, Germany. During this time, he has experienced the first large scale manufacturing challenges in cell culture. Dr. Cayli has worked later by Boehringer Ingelheim in Biberach as...

Dr Chaiken is an industry veteran with global expertise following a 23-year career at Pfizer where she held senior executive roles, including Chief Medical Officer for the company’s Biopharmaceutical Group for Emerging Markets. In this role, Dr Chaiken built a high-performing medical affairs...

Joan A. Chambers  Senior Consultant Tufts Center for the Study of Drug Development (Tufts CSDD)   Joan Chambers is a senior consultant advising research projects and the Center’s membership programs. She brings more than 30 years of senior management experience — across a variety of strategic...

Maya Chandrasekaran is an applied economist who specializes in impact evaluations, global health, and ethical and effective survey-based research. She is the current director of the Mercury Project, a consortium of 18 research teams studying vaccine access and uptake, at the Social Science Research ...

Lee-Jah joined AZ in 2021 and currently is the Vice President, Head of Clinical Development for V&I where he leads the Early and Late V&I clinical teams supporting the clinical development strategy for our vaccine and monoclonal antibody programs. Previously, he was the Head of Early...

Dr Ling CHEN received his medical degree from Shanghai Medical College in 1984. He received his PhD in Biochemistry and Molecular Biology from Indiana University School of Medicine, USA in 1992. Dr Chen completed his postdoctoral training in 1994 at the Dana-Farber Cancer Institute, Harvard Medical ...

Chaing-Yun Chen, Ph.D., is a researcher at CHO PHARMA in Taiwan, where he specialize in a range of activities within pharmaceutical development, particularly focused on carbohydrate-based vaccine development. With a Ph.D. in Chemistry and a comprehensive background in both preclinical and clinical...

Dr. Chen is the Frank M. Calia, MD Endowed Professor of Medicine at the University of Maryland School of Medicine, where he is the Chief of the Division of Geographic Medicine, Department of Medicine. He is an adult infectious disease physician-scientist with a specific interest in developing...

Dr. Robert T Chen has been active in research of vaccines and vaccine-preventable diseases for over 40 years, mostly at the US Centers for Disease Control and Prevention (CDC).  He played key roles in modernizing the vaccine safety infrastructure in the U.S. and elsewhere, including the creation of ...

Dr. Ghania Chikh, Senior Director, Vaccine Development, brings extensive experience to her senior leadership role at Acuitas Therapeutics, Inc. Dr. Chikh has spent much of her career working with vaccines and lipid nanoparticle (LNP) delivery technology. In fact, her PhD thesis was focused on...

Kati Chilikova is a Manager at Economist Impact, the insight and research arm of The Economist Group.  As Manager in the Health Practice, she leads diverse teams to design and deliver evidence-based health policy projects that tackle the world’s most pressing issues. She has experience in health...

Dr. Christensen was recently appointed as Global Head of R&D for Adjuvant Systems at Croda Pharma after 18 years in adjuvant research at Statens Serum Institut, Denmark. During his career, his research focus has been on pharmaceutical and immunological aspects of vaccine adjuvants and delivery...

Colonel Matthew G. Clark is the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical). He is responsible for leading themedical portfolio for the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND). ...

Tonya Colpitts is an accomplished professional with a proven track record in the global vaccine industry. Currently serving as Associate Vice President and Global Project Head for Vaccines at Sanofi, Tonya brings a wealth of experience and expertise to her role. With a strong background in research ...

Pär Comstedt is Vice President for Infectious Disease Vaccine Development at Evaxion, Denmark. He oversees Evaxion’s portfolio of vaccine projects targeting bacterial and viral infections, discovered using Evaxion’s AI-immunology platforms. Pär has been active in the vaccine development field for...

Dr. Cooke has over thirty years of experience in the vaccine industry.  He was previously CEO of NovaDigm Therapeutics, CEO of Mojave Therapeutics, COO at AVANT Immunotherapeutics and SVP at Ology Bioservices. Prior to his leadership roles in the biotechnology industry, he held several positions at ...

Lisa Cornbrooks serves as the Senior Director, National Health Campaigns at AMGA Foundation. In this role, she oversees the Rise to Immunize® campaign, a six-year initiative that has engaged 85 medical groups and health systems across 30 states to improve routine adult immunization rates. She...

Mr. Cornejo has a master’s degree in international development studies from George Washington University. He started his career in academia and many international organizations. He joined the Gavi Alliance in 2008 where he held different responsibilities, including the development and management of ...

Dr. Aaron Cowley is the Chief Scientific Officer (CSO) at ReciBioPharm (2019 to present), a leading Contract Development and Manufacturing Organization (CDMO) focused on Advanced Therapy Medicinal Products (ATMP), including but not limited to Live Biotherapeutic Products (LBPs), xRNA, pDNA and...

Taylor Craig is experienced in strategic feasibility, trial planning and site feasibility and pre-qualification for Phase I – III infectious disease and vaccine trials.  Her therapeutic areas of expertise include infectious disease and vaccines with significant experience running feasibility for...

Andrew Cwiertniewicz, MSN, RN, is a seasoned expert in vaccine clinical development with over 20 years of experience driving public health innovation. Based in Pennsylvania, he currently serves as the Senior Delivery Director for Vaccines at Fortrea (formerly Lapcorp), where he spearheads strategic ...

Experienced Chief Executive Officer with a demonstrated history of working and succeeeding in the  biotechnology and medical technology industires.

Dr. Rituparna Das is a physician-scientist and global leader in vaccine development, currently serving as Vice President and Therapeutic Area Head for Respiratory Vaccines at Moderna. In this role, she leads the clinical strategy and development of Moderna’s mRNA-based respiratory vaccine...

Dr. Kashmira Date is a physician, epidemiologist and global health leader with over 20 years of experience and leadership in both, public and private, sectors with clinical development/medical/scientific affairs in infectious diseases, vaccines, epidemiology, real-world evidence, pandemic...

Dr. Davinelli has 21 years of experience in clinical research. He joined PPD in November 2010 and currently serves as business optimization lead for vaccines and as strategic proposal development service lead for government and public health. Previously, he served as project manager and oversight...

As a previous Senior Policy Advisor at the FDA, as well as a seasoned leader within the CRO industry, Sugato has cultivated expertise in a plethora of regulatory pathways, including dossiers for combination products, expedited pathways, protocol development for medical devices, and more. During his ...

​​​​​​​Johann de Bruyn serves as the CEO at TASK Clinical Trials in South Africa. He holds an MBA from Bradford University (UK) and specializes in strategic planning, business development, and financial analysis for clinical research. Before TASK, de Bruyn founded Certus Capitol, a small business...

Michel De Wilde is a distinguished leader in the field of vaccine research and development, with a successful track record spanning over four decades.While at GSK, Michel played a key role in the development of novel vaccines, most notably against Hepatitis B and Malaria. As the former Senior Vice...

Dr. William Decker is a Professor in the Department of Pathology & Immunology at Baylor College of Medicine. Dr. Decker received a B.S. in Biology from Tufts University and a Ph.D. in Molecular in Human Genetics from Baylor College of Medicine in 2001. Following early career work in...

Antonio DiGiandomenico serves as Senior Director and Head of Microbial Antibodies and Technologies, Vaccines & Immune Therapies at AstraZeneca.  Dr. DiGiandomenico received his MS (Microbiology) from Duquesne University in 2001 and then his PhD (Microbiology) from the University of Virginia in...

Dr. Divangahi is an internationally renowned pulmonary immunologist whose overarching research focus is to investigate the regulatory mechanisms involved in innate and adaptive immunity to pulmonary pandemic infectious diseases and to broadly understand critical differences between protective and...

Dr. Kyle Doolan leads cross-functional teams in molecular biology, protein engineering and virology that perform experiments for operations and research and development. Kyle has been instrumental in enhancing the performance of Integral Molecular’s technologies and is an inventor on two of the...

Using Adjuvant Science to shape the future of human health.

Ruxandra Draghia-Akli, MD, PhD Executive Vice President, Head of Research & Development, Novavax Ruxandra Draghia-Akli, MD, PhD, is the Executive Vice President and Head of Research & Development (R&D) at Novavax with the responsibility of evaluating opportunities for its early and...

I direct the Laboratory of Malaria Immunology and Vaccinology, where research teams focus on pathogenesis, immunity, and vaccine development. I have extensive experience in human observational and interventional studies of malaria, including studies of controlled human malaria infections. As the...

Cynthia “Cindy” Dukes, PA, MT, currently serves as Senior Therapeutic Strategy Director for Avacare Clinical Research Network of 40+ multi-therapeutic sites.  With over 40 years of diversified clinical experience, Cindy is a distinguished professional and thought leader in the vaccine industry. Her ...

Peter is Deputy Director for Integrated Clinical Vaccine Development within the Global Health Division at the Gates Foundation.  In this role, he provides technical and strategic guidance on clinical development to the foundation’s program strategy teams.  His group works on accelerating vaccine...

Sheetij Dutta leads the Structural Vaccinology Laboratory, Biologics Research and Development Branch at the Center for Infectious Disease Research, Walter Reed Army Institute of Research (WRAIR). SVL is engaged in discovery and development of vaccine and biologics against parasitic, bacterial and...

Susanne Eder-Lingelbach, MSc, MBA, is leading Valneva´s global Clinical Development organization based in Vienna, Austria and as Vice President a member of the company´s leadership team. Valneva is a public, fully integrated, specialty vaccine company focused on the development and...

Darin joined Moderna in 2019 as the Head of Immunology in the Infectious Disease Research Group.  During his time at Moderna, Darin has led many efforts to develop novel vaccines using Moderna’s mRNA platform as well as the research efforts to further develop the mRNA platform and to understand key ...

Dr. Egan brings to CastleVax 25+ years of vaccine research and development experience. Prior to joining CastleVax, Dr. Egan served as the Chief Scientific Officer of Auro Vaccines LLC. Previously, Dr. Egan served as a Project Leader at the Bill and Melinda Gates Medical Research Institute and led a ...

Angela Eichler is currently the Director of Specialty Lab Services at Johnson County Clin-Trials (JCCT). Her expertise in isolation and cryopreservation of cell mediated immunity (CMI) samples spans over a decade. Ms. Eichler has worked extensively with pharmaceutical companies as well as...

Pernille Elverdal, PhD, has always been passionate about infectious diseases. She is known as an expert in this area with over 20 years of experience and a special focus on Pneumococcus, Legionella, Streptococcus and other bacteria causing respiratory diseases. Pernille is still a respected member...

Mark A. Emalfarb is the founder and CEO of Dyadic, as well as a member of its Board of Directors. Since founding Dyadic in 1979, he has led its transformation from producing ingredients for stone-washing jeans to developing and commercializing specialty enzymes and the proprietary C1 fungal...

Dr. Faissol is the Principal Investigator of the Generative Unconstrained Intelligent Drug Engineering program, which focuses on the computational design of antibodies and antigens at Lawrence Livermore National Laboratory. His primary research interest is in developing and integrating methods in...

Bill Falstich is Vice President of Pfizer’s Primary Care Category Global Supply Chain. His team of 50 colleagues manages supply for some of the world’s largest vaccines, a broad Internal Medicines portfolio, and Pfizer’s Paxlovid antiviral. His team also plays a critical role in the...

Dr. Finn is University of Pittsburgh Distinguished Professor of Immunology and Surgery. After receiving her PhD in Medical Microbiology at Stanford University in 1980 and completing her postdoctoral training in Immuno-oncology there in 1982, Dr. Finn started her research at Duke University and in...

Dr. Flores-Riveros completed his PhD and postdoctoral training in biochemistry andtranscriptional regulation at Johns Hopkins University School of Medicine. He laterworked at Bayer Pharmaceuticals, focusing on metabolic regulation, before co-discovering leptin’s role in angiogenesis, obesity, and...

Robert W. Forgey is a seasoned life sciences executive and entrepreneur with a proven track record of driving success in both emerging and established companies. As President & CEO of Iaso Therapeutics, he spearheads the company's strategic vision, securing crucial seed funding and guiding...

Dr. Cyrielle Fougeroux has an M.Sc. in immunology, microbiology, and virology with a specialty in immunology from the University of Paris Diderot (Paris 7), followed by a Ph.D. in immunology and infectious disease from the University of Copenhagen. Dr. Fougeroux has a deep knowledge of immunology...

Pascal Geldsetzer is an Assistant Professor of Medicine at Stanford University and a Chan Zuckerberg Biohub Investigator. He has won an NIH New Innovator Award to investigate the feasibility of applying causal effect estimation techniques from the social sciences to clinical research questions. As...

Dr. Douglas Gladue currently is an internationally recognized leader in bringing projects from concept to commercialization, with over 20 years of experience leading diverse research teams. As the Vice President for Veterinary Pharmaceutical Development at Seek Labs he leads a team to develop new...

Monica Goel Technology executive with over 20+ years of experience spanning digital accessibility, enterprise technology strategy, cloud computing, cybersecurity, data management, and software development across industries such as health insurance, risk management, and banking. Former Head of...

Steven K. Gold, M.D. is a life science entrepreneur and the CEO of Boost Biopharma, Inc., a company that he co-founded with four other experienced scientists and entrepreneurs. Steve has worked at the intersection of technology and business throughout his career. He is also the named inventor on...

Alejandra Hermosilla Gonçalves is a Senior Manager in Medical Affairs at Bavarian Nordic, a leading vaccine company. She joined the company in 2024 as a Medical Science Liaison, bringing a strong background in infectious diseases. Alejandra earned her medical degree from Fluminense Federal...

As Chief Commercial Officer at Verified Clinical Trials, Justin oversees Business Development & Strategic Partnerships with Pharma/Biotech sponsors, CROs, research sites (privately owned, networks and AMCs) and technology companies. Prior to joining VCT, Justin has worked at various industry...

Swati Gupta, DrPH, MPH, leads IAVI’s Emerging Infectious Disease product portfolio and the development of the organization’s overall scientific strategy. She has a particular focus in leveraging IAVI’s recombinant vesicular stomatitis virus (rVSV) platform and expertise to expand product...

Michinari Hamaguchi earned his M.D. and Ph.D. in medicine from Nagoya University, then he pursued his research at Rockefeller University in the U.S (1985-1988). He served as the President of Nagoya University from April 2009 to March 2015 before becoming the President of the Japan Science and...

Jill Hamaker is a seasoned government and public affairs professional with over two decades of experience and trusted relationships across the US Government and the private sector. The Hill newspaper recognized her as a “Top Lobbyist.”Previously she was Vice President and Head of Federal Government ...

Davidson Hamer, MD is a Professor of Global Health and Medicine at the Boston University Schools of Public Health and Medicine, the co-lead of the climate change and emerging infectious diseases research core at the BU Center on Emerging Infectious Diseases, and an attending physician in infectious ...

Christian Happi, is a Professor of Molecular Biology and Genomics and Director of the World Bank funded African Center of Excellence for Genomics of infectious Diseases, (ACEGID), Redeemer’s University, Ede, Nigeria.   He did his postdoctoral fellowship at Harvard University (2000-2003), and...

PwC and BCG Managing Director and Partner; leading the Public Health practicesOperation Warp Speed Senior leader and architect, from inception to vaccine roll outCo-Founder of successful start-up at SaponiQx (vaccine adjuvant); $0 to $250M valuation on exitSpecial Assistant to the President for...

Ian Hart is a seasoned professional in the field of vaccine manufacturing, currently serving as the Manufacturing Lead at the Coalition for Epidemic Preparedness Innovations (CEPI). With over 30 years of experience in the pharmaceutical and biotechnology industries, Ian has a proven track record of ...

Renee Hart serves as the President and Chief Business Officer of LumaCyte, bringing over 25 years of executive experience in life sciences operations and business leadership. Her broad and deep experience and diverse expertise across clinical development, commercialization strategies, bioanalytical ...

Jian (Jason) He has 18 years of vaccine development experience with growing responsibilities in vaccine R&D and commercialization of recombinant proteins, conjugates, and VLPs with Merck & Co., WuXi Biologics, and WuXi Vaccines. Jason received his B.S. in Chemistry from Peking...

Jennifer is a leader in McKinsey’s Pharmaceuticals & Medical Products Practice, and she serves pharmaceutical and high growth biotechnology companies on innovation and go-to-market strategies for biological therapeutics and vaccines. A scientist by training, Jennifer leads McKinsey’s knowledge...

Caroline is veterinarian and animal health strategy expert with over twenty years’ experience working in the animal health and nutrition sectors in the US, Europe and globally. She spent ten years at Zoetis where she served as Vice President of Commercial Development & Lifecycle Management and...

Klaus Hellmann, DVM, is the Head of Europe CRO at Argenta, bringing extensive expertise in animal health product development. He has played a pivotal role in securing successful marketing authorisations for numerous products across various organisations. Klaus studied veterinary medicine at the...

Damian Hiley MBA,  is the Director of Business Development at Desert King International. Since joining the company in 2013, he has played a key role in launching GMP QS-21 and other saponin-based vaccine adjuvants. He oversees production from GMP facilities in Chile to CMOs in Europe, ensuring...

Professor Adrian V. S. Hill FRCP, FRS is the Director and Founder of the Jenner Institute, and Mittal Professor of Vaccinology at Oxford University. He is a passionate believer in the power of molecular medicine to address many of the most egregious health care inequities globally. His group have...

Dr. Richard E. Hill, Jr., (Rick) received a D.V.M. degree from Michigan State University in 1983 and following graduation, worked in private veterinary practice. In 1985, he joined the USDA and spent the majority of his career working in the Biologics Program as an Inspector, Epidemiologist, and...

Dr Tim Hirst is the Chairman and CEO of GPN Vaccines (https://gpnvaccines.com) an Australian biotechnology company conducting clinical trials of a new vaccine against the world’s foremost bacterial pathogen, Streptococcus pneumoniae. He is an entrepreneur, investor and internationally acclaimed...

Bernard Hoet is Vice President, Head of Medical strategy at Bavarian Nordic, a fully integrated pure-play vaccine company. He joined this company early 2020, at the time of acquisition of the rabies and tick-born encephalitis vaccines from GSK, to build up the Medical Affairs department, and...

Kee-Jong Hong (BS, Seoul National Univ; MS, Seoul National Univ; PhD, Texas Tech Univ) is currently a Professor at the Department of the Microbiology, Gachon University School of Medicine, Korea, and a Program Manager of Division for Health Security at Korea Advanced Research Project Agency for...

Dr. Honigmann is the founder and CEO of AmerStem Inc., based in Camarillo, CA. She has decades of experience leading diverse teams of scientists and technical experts in biotechnology and vertical farming.During the early months of the 2020 SARS-CoV-2 pandemic, she and her colleagues embarked on...

Peter J. Hotez, M.D., Ph.D. is Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine where he is also the Co-director of the Texas Children’s Center for Vaccine Development (CVD) and Texas Children’s...

Dr. Pamela Housh is a life sciences professional with a PhD in Microbiology and Immunology and an EMBA specialized in Executive Leadership. Her passion lies in purposeful project involvement, fostering collaboration, and nurturing impactful partnerships. With a collaborative, curious, and...

Xuefei Huang is a MSU Foundation Professor at Michigan State University. He is a full professor jointly appointed in the Departments of Chemistry and Biomedical Engineering, as well as the Chief of the Chemical Biology Division of the Institute for Quantitative Health Science and Engineering. His...

Richard Hughes IV, J.D., M.P.H. is a Partner at the Washington, D.C. health care law firm, Epstein, Becker & Green and a Professorial Lecturer in Law at the The George Washington University Law School. His practice, teaching and thought leadership focus on access to preventive health...

  Lucas is a seasoned expert in animal health, immunobiology, and veterinary pharmaceutical innovation, with a proven track record of driving R&D initiatives and delivering impactful solutions for both companion and food animals. Throughout his career, he has held key leadership roles at...

Manish Jain, MD is a board-certified Rheumatologist and Internist in practice for over 12 years. He received his medical degree from Rush Medical College and completed his Internal Medicine Residency at the University of Michigan in Ann Arbor followed by Rheumatology Fellowship at New York...

Dr. Juan Carlos Jaramillo, MD, is a seasoned Research and Development leader with extensive expertise spanning medical affairs, clinical development, pharmacovigilance, regulatory affairs, market access, and pricing. As Chief Medical Officer at Valneva, he builds on a distinguished career holding...

Elizabeth Joseph has a B.S. in Chemistry from Indiana University, and is a Research Scientist II at Simtra BioPharma Solutions in Bloomington, IN.  She is a member of the Development and Pre-Commercial Services team, offering contract development services including formulation...

Chrissie Juliano, MPP, is Executive Director of the Big Cities Health Coalition. She served as the organization’s Deputy Director from December 2014 to June 2015.Chrissie has a long track record of working collaboratively with partners to enact real policy change for the public’s health. Prior to...

Andrew Jurgensen currently serves as a Senior Global Project Manager at Accelerated Enrollment Solutions (AES), where he is responsible for leading project delivery across a global site network. With over a decade of experience in clinical research and project management, Andrew brings a unique...

Ashley is the Founder and CEO of Torigen Pharmaceuticals—a startup that resulted from her graduate thesis project at the University of Notre Dame. Ashley graduated from the University of Connecticut in 2012 with an undergraduate degree in Pathobiology and then chose to continue her...

Ramaswamy Kalyanasundaram, PhD, assistant dean for research and head of the Department of Biomedical Sciences at the University of Illinois College of Medicine Rockford, is the professor of microbiology and immunology and is the Michael L. and Susan M. Glasser Endowed Professor. ...

Nektaria Karavas is the Global Director of Business Development for Nasal Vaccines, Antivirals at Aptar Pharma. Ms. Karavas joined Aptar Pharma in 2004 and has held various commercial roles executing long-term strategy within key customer and global accounts in North America focusing on nasal drug...

Sarah is a health care journalist that specializes in the policy and politics that affect the pharmaceutical industry. She covers the US Food and Drug Administration, Centers for Medicare and Medicaid Service and Congress and other parts of federal and state government. Her work explores how...

Anne has more than 15 years of experience in clinical and translational research.  Before joining Parexel, she was lead medical director, overseeing teams that researched new therapies for graft-versus-host disease and novel antibiotics.  She also served as program officer at the Bill and Melinda...

I have always been interested in infectious diseases and approaches to prevent them, primarily with the application of vaccines, in both humans and Animals.I obtained my PhD in Virology from Harvard university in 2009 and before that I had my DVM from Addis Ababa University in Ethiopia and MSc in...

Dr. Sheila Keating is a distinguished leader in the field of immunology, renowned for her expertise in driving groundbreaking work in infectious diseases, vaccines and recombinant polyclonal antibody therapeutics. With over two decades of experience in infectious disease research, Dr. Keating has...

Musaddiq Khan has over 15 years of experience in clinical research, with a strong background in early-phase clinical development. His career spans leading roles at Parexel, Roche, AstraZeneca, and Eli Lilly, where he was instrumental in the operational delivery of the First-in-Human study for...

Kevin P Killeen, PhD is the Chief Scientific Officer at Matrivax Research & Development Corp.  Dr. Killeen has extensive training in the fields of molecular biology, microbiology, protein chemistry, immunology, and vaccinology.  His undergraduate BS degree is from Stonehill College (biology and ...

Dr. Hani Kim’s educational background is in biology, and she later extended her research into public health. She currently plays an active role in global health as the Executive Director of the RIGHT Foundation. Her career includes positions as a postdoctoral researcher at the Max Planck Institute...

Alasdair King qualified as a veterinary surgeon from Glasgow University in 1990.  After 11 years in mixed practice he joined Intervet UK as livestock veterinary advisor.  Amongst other roles in the UK, he took on responsibility for company pharmacovigilance as the National PV Manager, and developed ...

Dr. Klein is a Professor of Molecular Microbiology & Immunology, Biochemistry & Molecular Biology, and International Health at the Johns Hopkins Bloomberg School of Public Health and Department of Medicine at the Johns Hopkins School of Medicine. She co-directs the Johns Hopkins Center for...

A passionate believer in science and the value vaccines bring to society, Charles leads a team of talented CMC scientists focused on commercial supply of vaccines, as well as supporting efforts in vaccine development and regulatory advocacy.  Working in the vaccines industry since 1995, and within...

Selçuk Koçhan is the Co-Founder and CEO of MOBIQU, a company that is transforming cold chain packaging solutions swith smart, temperature-controlled packaging powered by IoT technology. MOBIQU helps businesses track and protect temperature-sensitive products like medicines, vaccines, and biotech...

With a background in chemistry and nanomaterials, Kathryn has focused on the translation of academic research breakthroughs into impactful products, working across disciplines of biology, chemistry, and engineering. Prior to co-founding Vaxess, Kathryn was a postdoctoral research fellow in the...

Tristan Kovačič is a project manager at the leading developer of monolith technology Sartorius BIA Separations in the PC4 Process Analytics Development department, where he is responsible for the development of analytics, purification and manufacturing of lipid nanoparticles and other non-viral...

As Chief Scientific Officer, Michael is responsible for LimmaTech’s scientific development, focusing on pipeline development and operational R&D performance. Michael has a PhD in Biochemistry from the Swiss Federal Institute of Technology, Zurich (ETH Zurich) and developed a broad experience in ...

Dr. Lakshmi Krishnan is the Vice-President of Life Sciences at the National Research Council, Canada (NRC). In this capacity, she oversees the Human Health Therapeutics, Aquatic and Crop Resource Development and Medical Devices research centers. As a globally recognized Life Sciences...

Mahesh Kumar has over 35 years in the research and development of vaccines. Starting in the deverlopment of avian vaccines, he now oversees the global vaccines portfolio for all species at Zoetis, the worlds largest animal health company. His interests lie in immunology, vaccines and emerging...

Dr Prabuddha Kundu has a M.Tech, PhD in Biomedical Engineering from IIT Bombay, and specialized in protein therapeutics and scale up including MAbs. He has over 25 years of experience in various companies, and positions, including establishment of production facilities, for therapeutics and...

Craig joined iosBio from CANVAX, an international consulting business specialising in vaccines. Previously, he was Medical Adviser on the Vaccine Leadership Team at Pfizer Canada where, amongst other projects, he led a team to sucessfully extend the indication of a pediatric vaccine. At GSK he was...

Rekha Lakshmanan, M.H.A. is the Chief Strategy Officer for The Immunization Partnership, a non-profit organization educating about and advocating for immunizations. She has extensive experience working with state legislatures and successfully advocated for the passage of multiple pieces of...

Michaël is an accomplished leader in biotechnology and pharmaceutical quality management with over 15 years of expertise in analytical method validation, process improvement, and team leadership. With a PhD in Molecular Biology, Michael has contributed significantly to scientific research and...

Heikki holds a PhD in Biochemical Engineering from the University of Cambridge. He has over 20 years commercial & scientific experience in life sciences and has a track record of developing high growth technology businesses. Heikki has published scientific papers and is named inventor on a...

Dr. Kevin Lang is a recognized leader in immunophenotyping for clinical trials and spectral flow cytometry, particularly in cell and gene therapies like CAR-T. His award-winning research includes a 2024 WRIB Poster and an AAPS PharmSci360 presentation regarding CAR-T therapy. Dr. Lang is excited...

Luigi Lay graduated in Chemistry in 1990 and was awarded a PhD in Chemical Sciences in 1994 at the University of Milan, working on the synthesis of Streptococcus pneumoniae capsular polysaccharide fragments. After an EU-funded post-doctoral fellowship in the research group of Prof. Richard...

Alexandre Le Vert is the Executive Chairman and Co-Founder of Osivax. Alexandre is a serial entrepreneur with a fascination for biology and more than 20 years of experience in healthcare ranging from research and development to commercialization of vaccines and therapeutics.He has led several...

Business Development Director of IVI In charge of capability strengthening for Low and Middle Income countries Biomanufacturing In charge of intellectual property

I have worked continuously on infectious disease research since 1969. I co-founded the Center for Vaccine Development in 1974 and was Director until December 2014. I retired in March 2025. Throughout my career I have spent considerable time in low-and middle-income countries working on the...

Jay M. Lieberman, M.D. is Senior Medical Director at Parexel with extensive vaccine clinical development experience. Before joining Parexel in 2024, he was Vice President of Clinical Development at Meissa Vaccines, where he oversaw the development program for investigational intranasal...

Elizabeth Linderbaum is Deputy Director of Regulatory Affairs at the National Association of Community Health Centers (NACHC). In this role, she leads the Federal regulatory portfolio, with her main policy areas of focus including the 340B drug pricing program, Medicare and Medicaid issues, as well ...

Rushit N. Lodaya is a distinguished leader in vaccine formulation and Drug Product R&D, bringing over a decade of pharmaceutical industry experience with specialized expertise in vaccine antigens, adjuvants, and nucleic acid encapsulating nanoparticles. Currently serving as the Associate...

Keir Loiacono, Esq. Chief Executive Officer Mr. Loiacono brings nearly 20 years of transactional experience from the biotech, pharmaceutical and medtech industries. A patent lawyer by training, Mr. Loiacono represented companies of various sizes in all stages of transactions, including licensing...

Dr. Nicolette Louissaint serves as the senior vice president for policy and strategic planning for the Healthcare Distribution Alliance. In this role, she leads the organization’s work to build policies and strategic approaches to build supply chain resilience and reinforce the role of healthcare...

Marie-Louise Lunn is Global Product Manager at Novo Nordisk Pharmatech with on enzymes for bioprocessing. She holds a Ph.D. in molecular biology and drug discovery from the University of Copenhagen, Denmark. After working as a postdoctoral researcher at the Salk Institute for Biological Studies in...

Angela Luttick is a virologist with more than 20 years’ experience in the discovery, development and commercialisation of novel drugs. Well accustomed to leading multidisciplinary biology teams in the biotech and pharmaceutical industries. Angela is a co-founder and Executive Vice...

Jessica Malaty Rivera is an infectious disease epidemiologist and award winning science communicator. She earned her MS in Emerging Infectious Diseases from the Georgetown School of Medicine and has dedicated the last 15 years of her career to emerging disease surveillance, public health...

Mr. Mallon has 25 years of corporate development experience in the biopharmaceutical and medical device industries, where he has successfully identified market opportunities and stimulated product/business growth. He brings specific expertise in corporate strategy and development, alliance...

Dominic Mancini brings 15+ years of experience working the interfaces between Analytical Development, Process Development, Quality, and Manufacturing Science to OrganaBio. A lifelong learner, Dominic enjoys solving the many scientific and operational challenges presented in the field of cell and...

Christian W. Mandl is a consultant for industrial, academic and non-profit organizations on translational aspects of vaccines, cancer immunotherapy and global health. His engagement with the health care industry and public health organizations includes roles as Co-founder and Chief Scientific...

Alessandro Manenti graduated in Biology obtaining his Bachelor’s Degree in 2009 and a Master’s Degree in Molecular Evolution in 2013 at the University of Siena. He worked for six months in a big company in the field of Life Sciences. In November 2013, he won a competition for PhD students in...

Alex Mann is a senior clinical scientist with over 25 years’ experience working in infectious and respiratory disease clinical research at hVIVO.He has significant expertise in leading the design, execution, and analysis of human challenge studies for efficacy testing, using pathogens such as...

Monique K. Mansoura is the Executive Director for Global Health Security and Biotechnology at The MITRE Corporation. She brings technical, policy and business expertise from both public and private sectors. Her focus is on U.S. competitiveness and sustainability of the biotechnology industrial base ...

Dr. Gerben Marsman obtained his doctorate degree at Sanquin Research (Amsterdam, The Netherlands) and completed a post-doctoral research position at the Max-Planck Institute for Infection Biology (Berlin, Germany). He joined the VFI in 2023 as a Project Manager and is currently Head of Alliance...

Former CMIO Kaiser Permanente, SCALLed digital transformation at Kaiser PermanentePhysician with deep experience in Internal Medicine, Critical Care, Trauma medicine, Hyperbaric medicine, Primary Care, Preventive Medicine, healthcare for the unhoused.CMIO, operating partner, ACPFounder CCD and CDA...

Alison Buttenheim is Professor of Nursing and Health Policy at the University of Pennsylvania, where she co-directs the Behavioral Economics and Global Health Insights (BEGIN) Lab and serves as Behavioral Design Lead for the Center for Health Incentives and Behavioral Economics. Her research...

Dr. McNamee is Director of Scientific and Reguatory Affairs for the Animal Health Institute, Washington DC, where she facilitates engagement between regulators and the animal health industry.  MJ is a seasoned veterinarian and legal professional with over 25 years of experience in veterinary...

Justine McPartlan, B.Sc., is a Scientist at Tiba Biotech. During her undergraduate research at MIT, she focused on novel RNA vaccine strategies to fight infectious disease and cancer at the Whitehead Institute for Biomedical Research under Dr. Hidde Ploegh. This work culminated in a 2016 PNAS...

Dr. Yimy Mena graduated with a chemical engineering degree from the National University of Colombia and completed both his MSc and Doctorate degrees in Biotechnology at the National Autonomous University of Mexico. With more than 20 years of industry experience in both small and large...

Dr. Shannon Miller is the Vice President of Operations at Inimmune, where she also leads the company’s immunology R&D team. Prior to serving as VP of Operations, Dr. Miller previously served as an Investigator and Director at Inimmune and held a faculty position at the University of...

Dr. Dal-Hee Min is currently a Professor at the Seoul National University, and CTO and co-founder of Lemonex Inc. She received her Ph.D in Chemistry from the University of Chicago. After post-doctoral research at MIT, she started her independent academic career at KAIST (Korea) in 2007 and moved to ...

Hajir is a forward-thinking leader with over 13 years of experience in the pharmaceutical industry, specializing in bringing strategic visions to life while keeping client needs and patient outcomes at the forefront. With a deep passion for innovation, he excels in integrated CDMO and CRO...

Sally Mossman heads up the portfolio of research and early development stage programs at Sanofi Vaccines and sits on the Vaccines R&D Leadership Team for the company.  Many of the novel programs in her portfolio are leveraging Sanofi’s proprietary mRNA technology accessed through the...

Zeshan Muhammedi is a founder and Managing Partner of MBX Capital. He holds board roles at MBX partner companies Attivare Therapeutics, Cloudcath, Mae Health, AmacaThera, and SecureAire.  Previously, he was the CEO of FundRx, a healthcare and life sciences investment marketplace. Prior to...

Iona Munjal, MD FAAP, is a seasoned leader in the pharmaceutical industry, currently serving as the Vice President of Pfizer Vaccines. With over 15 years of experience in vaccine development and commercialization, Iona has a proven track record of driving innovation and strategic growth in the...

Marta G. Murreddu is a seasoned professional in clinical research, virology, and project management. She successfully oversaw clinical trials, managed client communications, and ensured adherence to timelines and budgets. From 2021 to 2023, she led Clinical Virology Services at Viroclinics, where...

Usman is a paediatrician and an expert in vaccine clinical development who works at the Bill and Melinda Gates foundation as a senior program officer for vaccine development and impact in AMR, Pneumonia and pandemic preparedness. Previously he was at the GSK Vaccines Institute for Global Health...

Sujatha Narayan, is the Principal Regulatory Program Director in Pharma Technical Regulatory at Genentech, a member of the Roche Group. In this role, Sujatha is responsible for ensuring regulatory compliance, conformance globally and effective issue management across all Chemistry, Manufacturing...

Dr. Nasar is the Senior Principal Scientist at Tonix Pharma, a company focused on bringing novel therapeutics and diagnostics to prevent and treat central nervous system disorders, infectious diseases, and rare diseases. Dr. Nasar is an experienced virologist researching and developing vaccines and ...

David has over 18 years of experience in biomedical and basic research, as well as 18 years in the biotech industry. He co-founded eEnzyme in 2004 before exploring new opportunities in 2005. After initially returning to research, he transitioned into sales, holding positions at Life Technologies...

Dr. Nguh is a global health scholar and practitioner. His scope of practice has been in maternal newborn and child health programs, immunization, family planning and reproductive health, nutrition, health systems strengthening, water/sanitation/hygiene, malaria, prevention of mother-to-child...

Hanna Nohynek is Professor with MD PhD, who has special competences in vaccinology, international and travel health (Finnish Medical Association). She works as Chief Physician in the Unit Prevention of Health Threats of the Department of Public Health in the Finnish Institute for Health and Welfare ...

Brian K. Nunnally, Ph.D. is the Vice President and Enterprise Head of Quality Control for CSL. Being the best quality control unit drives his passion. Prior to this role, he served as the Head of Quality Control for the Seqirus division of CSL after being promoted from the Site Head of Quality for...

Dr Ahmed OGWELL is currently the Vice President for Global Health Strategy at the United Nations Foundation (unfoundation.org). In this capacity he leads the broad portfolio of global health policy, advocacy, thought leadership and resource mobilizatiopn for key UN priority initiatives. He is a...

I am a Senior Advisor in R&D in GSK Vaccines, since 2018, and a GSK Fellow, since 2019. Prior to this I was the Global Head of Discovery Support and New Technology in GSK Vaccines. Until 2015, I was the Global Head of Vaccine Chemistry and Formulation Research for Novartis Vaccines. I have...

Walter A. Orenstein, MD, is currently a Professor Emeritus of Medicine, Epidemiology, Global Health, and Pediatrics at Emory University.  From 2008 through 2011, Dr. Orenstein was Deputy Director for Immunization Programs at the Bill & Melinda Gates Foundation. His primary focus at the...

Dr. Masaru “Rusty” Oshita, is a board-certified Emergency Medicine physician with extensive experience in patient care and entrepreneurship. He runs a network of Urgent Care centers throughout Sacramento and is dedicated to providing thoughtfulmedical care in the community. Dr Oshita is recognized...

Julia is a leader with over 25 years of experience in clinical research and a passion for leading teams through challenges to success. She is currently focused on the operational oversight and leadership of a large portfolio of vaccines trials for one of PPD’s key clients. Following earlier roles...

Sylvia Park-Ekecs is the Global Head of Consumer Experience + Design/CXO at Sanofi and an award-winning design visionary and leader with deep expertise in branding, user experience (UX), design, and management across print, digital, and multi-platform ecosystems. With a strong technical...

Heenal Patel is the Head of Strategic Partnerships at Paratus Clinical Research, bringing over 15 years of experience in healthcare with a strong background in clinical nutrition and medical science. Holding degrees from New South Wales, Australia, she transitioned into clinical research four years ...

Gabriela Paz-Bailey, MD, PhD, MSc, DTM&H is the head of the Dengue Branch (DB) in the Vector-Borne Diseases Division (DVBD) of the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), in San Juan , Puerto Rico. Dr. Paz-Bailey earned her degree in Medicine and Surgery from the ...

Dr. Martin Pech is a trained biosystems engineer who began his career in the industry with a company in Germany, working in the CTM department. He spent two years in this role before moving on to positions at universities. For five years, he worked as a scientist at the University of...

Cathy Peters is Strategic Director, State and Local Campaigns for the American Cancer Society Cancer Action Network (ACS CAN).  Cathy has held several roles at ACS CAN, starting in field operations in the Midwest and moving into promoted positions on the national team focused on providing strategic ...

Nikolai Petrovsky is a physician scientist with research interests in vaccines, adjuvants and immuno-informatics. He is currently a Professor of Immunology and Infectious Disease at the Australian Respiratory and Sleep Medicine Institute and a Research Professor at the Institute of Molecular...

Dr. May Pidding is currently the Director of Microneedle Array Path (MAP) Product Management, where she serves as the global commercial focal point for LTS’s MAP portfolio.Dr. Pidding earned her Bachelor’s degree in Biology in 1993 from Boston University and completed her Ph.D. in Biomedical...

Amy Pisani, MS CEO Vaccinate Your Family Amy Pisani is a distinguished expert in the field of vaccine advocacy and education, with a remarkable tenure dating back to 1996 when she joined Every Child By Two (now known as Vaccinate Your Family). As the Chief Executive Officer, she has played a...

Dr. Robert Popovian is the Founder of the strategic consulting firm Conquest Advisors. He also serves as Chief Science Policy Officer at the Global Healthy Living Foundation, Senior Healthy Policy Fellow at the Progressive Policy Institute, and Visiting Health Policy Fellow at the Pioneer...

Dr. Pottala received his MS in biostatistics from the University of Minnesota, Twin Cities in 2007. He began his career in research as a biostatistician at South Dakota Health Research Foundation and the VA Medical Center in Sioux Falls, SD. In 2012, he received his Ph.D. in computational science...

Stan has over 20 years of experience in vaccine development, biologics, and cell/gene therapy, with a strong background in GMP biosafety, GLP technical operations, and commercial strategy. He holds a Bachelor of Science from Pennsylvania State University and an MBA from Alvernia University. His...

Bali Pulendran, PhD Violetta L. Horton Professor, and Co-Director. Institute for Immunity, Transplantation and Infection, Department of Pathology, Department of Microbiology and Immunology, Fellow at ChEM-H (Chemistry, Engineering and Medicine for Human Health), Stanford University School of...

Lisa Purcell has been an Entrepreneur-In-Residence at Third Rock Ventures since May 2024. Her career has been dedicated to the development of therapies within the immunology and infectious disease areas. During the COVID-19 pandemic, she co-chaired the ACTIV partnership established by the...

Amy Purse is Biological Regulatory Affairs Advisor at Elanco Animal Health with over 20 years experience in the animal health vaccine industry.  Her expertise is in USDA-CVB regulations required to license and maintain approvals for vaccine and bioproducts for all animal species and is currently...

Dr. Martin Rabel is a dynamic thought leader in the biopharma industry, currently serving as the Global Sales Specialist - Biopharma Services at Cytiva. In this role, Dr. Rabel leverages his extensive expertise to drive global sales and support biopharma clients, focusing on...

Marlen Ramirez serves as Vaccinate Your Family’s Program Coordinator supporting VYF’s advocacy and education work. Marlen is an experienced Community Health Worker (CHW) and Community Health Worker Instructor (CHWI). She is a passionate advocate for health promotion and health equity, evidenced by...

Dr. Elizabeth Reap is an experienced immunologist with over 25 years of expertise in academic and CRO environments, focusing on oncology, immune monitoring, vaccines, and cell and gene therapies. She holds a Ph.D. in Microbiology from Clemson University and completed a Post-Doctoral Fellowship in...

Dakshina Reddy is a regulatory professional with over 25 years’ experience in drug regulatory affairs and clinical research. He has expertise in global drug regulatory strategy, drug development and regulatory life-cycle management. He is experienced in working with leading Regulatory Authorities...

Max is the Head of Business Strategy & Operations and the Chief of Staff at Artyc, where he focuses on all things business--from growth and partnerships to recruiting and fundraising. With a background in consulting and deal-making at IBM, he brings expertise in optimization, business...

Dr. Shon Remich is a passionate physician-scientist who has dedicated more than 25 years of his career to public and global health. He has been at the forefront of some of the largest public health challenges of the last century. During his 23-year military career, he completed board certification...

Dr. Hagen Richter joined WACKER in 2016 and currently serves as Director of Nucleic Acid Research with the WACKER central R&D hub in Munich, Germany. This team of approximately 30 scientific and technical experts focuses on research innovations and both academic and industry partnerships to...

 Bridget has worked in the health care field for over 25 years in both clinical and the bio-pharmaceutical industry. She has spent 17 of those 25 years focusing on vaccines and vaccine preventable diseases. Bridget’s need to understand the real-world journey of the sites and participants in...

Ruben Rizzi, physician by training, SVP of Global Regulatory Affairs at BioNTech. I joined the company in December 2019 just before the pandemic, and I have been the global regulatory lead for BioNTech for our COVID-19 development. Currently, I am still supporting the lifecycle of our COVID-19...

Dr. Robb received his B.S. in Animal Science from Cornell University in 1977 and his D.V.M. in 1981.  He practiced veterinary medicine in northern N.Y. before completing an M.S. in epidemiology at the University of Pennsylvania. He completed a residency in Veterinary Nutrition and is Board...

Joanie Robertson is a program advisor at PATH currently leading the portfolio on supply systems and equipment within the Medical Devices and Health Technologies program. A seasoned professional with over 30 years of work experience, including four years working for PATH in Vietnam (2009-2013) and...

Dr. Kate Rochlin has served as IN8bio’s Chief Operating Officer since December 2021 and previously as their VP, Operations and Innovation. She has 19+ years of expertise in strategic company development & operations, IP, CMC, and Clinical manufacturing of advanced therapies. She was previously...

Dr. Carla Rodriguez-Watson is the Director of Research for the Reagan-Udall Foundation for the FDA. Dr. Rodriquez-Watson is focused on continuously developing and enhancing a portfolio of work that leverages real-world data and experiences to inform and conduct clinical and post-market drug safety...

Ms. Rosen has spent nearly 20 years working in non-interventional studies, initially as a project manager and oversight director, and now within the strategic delivery team of non-interventional studies focusing on safety and vaccines. Ms. Rosen has global experience in primary data collection...

Candice Roux is an experienced Program Manager within the Grants, Innovation, and Product Development (GIPD) unit at the South African Medical Research Council (SAMRC). With a strong background in the reserach and development sectors, Candice brings a unique blend of skills in portfolio...

Debra Ruh, an Advocate for Inclusion & Technology for Good, is a globally recognized market influencer and advocate for the inclusion of people with disabilities. With over 500,000 followers on social media, she is among the top 2% of voices on LinkedIn, making her a powerful voice in the...

Olli is a former high-stakes poker professional who left the tables to found Psyon Games in 2013, to combine the power of games with science. He studied chemistry, physics and cell- and molecular biology, and game psychology at the University of Jyväskylä, Finland. The game and life science...

Dr. Kevin Russell is currently Section Head, Pediatric Vaccines, Global Clinical Development, at Merck Research Laboratories in Upper Gwynedd PA, after serving as Section Head for the Adult and Adolescent Vaccines Section from 2016 to 2022.  Before September 2016, Dr. Russell served as the US...

Dr. Daniel Salas Peraza, MD, MSc Executive Manager, Special Program, Comprehensive Immunizations (CIM) Pan American Health Organization/World Health Organization, (PAHO/WHO) Dr. Salas is the Executive Manager of the Comprehensive Immunizations Program (CIM) and has more than twenty years of...

TARUN SALUJA, MBBS, MD, PDCR, PGDBADr. Saluja is an expert on the development and evaluation of vaccines and is the Head of Clinical Development at International Vaccine Institute (IVI), whose mission is to discover, develop and deliver safe, effective, and affordable vaccines for Global Health. ...

Tyler Sandberg is a scientist holding a PhD in vaccine immunology from the Karolinska Institute and a master’s degree in immunology and infection biology from Uppsala University. His doctoral research involved conducting several vaccine studies to examine human immune responses to various...

Dr. Catherine Sanders is the Vice President of Business Development at Ozette Technologies, a commercial stage company focusing on novel approaches to single cell analysis to accelerate drug development. Prior to joining Ozette, Catherine served as Vice President of Research and Business...

Dr. Sardesai founded Geneos after building Inovio Pharmaceuticals into a Phase III cancer and infectious disease immunotherapy company serving as its Chief Operating Officer. He held positions of increasing responsibility after joining the company in 2006 where he helped formulate the company’s...

Dr. Giuseppe Sautto is Assistant Professor at the Cleveland Clinic Florida Research and Innovation Center. His main expertise is focused on antibody discovery and characterization, especially for infectious diseases-associated pathogens, including hypervariable, respiratory...

Cheri’s primary focus is to foster stronger, more productive relationships between Sponsors, CROs, and research sites. Her ability to 'speak the language' of both sides enables her to bridge gaps, facilitate smoother collaborations, anticipate potential issues, propose innovative...

Alex Schmidt serves as Head of Vaccine Development at the Gates Medical Research Institute.  He joined Gates MRI in 2018, after 7 years with GSK Vaccines, where he led clinical vaccine development programs for dengue, RSV, and influenza virus vaccines. Prior to joining industry, he spent ten years...

Dr. Schmidt is an expert in vaccine development with over 20 years of experience, specializing in infectious diseases and cancer vaccines. Throughout her career, she has built a strong track record in immune monitoring, regulatory affairs, and quality control. As Head of Immune Monitoring at...

Hanneke Schuitemaker, Ph.D., has been Valneva’s Chief Scientific Officer since June 2024 and, as such, responsible for the pre-clinical and translational R&D and CMC strategy and execution, working on prophylactic vaccines against chikungunya, Lyme disease, Zika, Shigella, EBV and ETEC. Prior...

Joachim Seipelt is an experienced biotech manager with a strong background in virology and vaccine development. He has experience in research (Boehringer Ingelheim, Max Perutz Labs Vienna), company co-founding (AVIR Green Hills Biotechnology), managing large governmental funding programs (Austria...

Dr. A. Selvapandiyan has been a prominent figure in vaccine development, with over 35 years of experience post-Ph.D. in molecular biology, focusing on molecular cell biology, diagnostics, immunology, and vaccinology. He has served as a Senior Research Scientist at the International Centre for...

Angela K. Shen, ScD, MPH Adjunct Associate Professor in the School of Medicine and Senior Fellow at the Leonard Davis Institute of Health Economics University of Pennsylvania, and retired Captain in the US Public Health Service.  Dr. Shen is a vaccine policy expert and health services researcher...

Lora Shimp has over 30 years of experience in international development and maternal and child health, particularly in immunization program implementation and leadership. With her background in epidemiology, international primary health care, and communication and behavior change, Ms. Shimp has...

Natalie Silmon de Monerri is a microbiologist with >18 years of industry and academic experience in microbiology and infectious diseases. Natalie received her MBiol degree in Molecular and Cellular Biology from the University of Bath in the United Kingdom, after which she earned her PhD in...

George Simeon is the CEO of Curevo Vaccine. He has over 30 years of experience in the healthcare sector working with multinational firms, start-ups, and not-for-profits. He has worked in biotech, pharmaceuticals, medical devices, IVD, and healthcare convergence technologies. He has worked across...

Anushua Sinha is a Senior Principal Scientist in Global Clinical Development at Merck & Co. She is the Clinical Sciences Team Lead for the clesrovimab program. She completed her clinical training in internal medicine, pediatrics and infectious diseases at Massachusetts General Hospital and the...

Jeffrey Skolnik, M.D. Senior Vice President, Clinical Development Dr. Skolnik leads INOVIO’s clinical development programs, focusing on HPV and immuno-oncology DNA medicines. He is a key member of the leadership team overseeing these global clinical assets.  Dr. Skolnik has held several leadership ...

Lori Sloate is a global health leader with over 25 years of experience driving initiatives to meet Sustainable Development Goals. She’s worked with the UN Foundation, Gavi, the Vaccine Alliance, and WHO, leading strategies for sustainable health financing, global immunization, and public...

Denise Octavia Smith, MBA, CHW, PN is the inaugural Executive Director of the National Association of Community Health Workers, Visiting Scholar at the Harvard Medical School Center for Primary Care Program in Global Primary Care and Social Change, Aspen Institute Healthy Communities Fellow, and a...

Igor Smolenov, currently the Chief Development Officer of Arcturus Therapeutics (San Diego, USA), is a recognized vaccine development expert with a proven record of accomplishment in small biotechnology and large pharmaceutical companies. He contributed to successfully developing and licensing...

Dr. Snowden joined GlaxoSmithKline in 2015 where she has held both global and US medical affairs appointments. She currently serves as Medical Director, Vaccines Clinical & Medical Affairs, US for the adult RSV portfolio. Dr. Snowden holds bachelor’s degrees in biology and chemistry from Howard ...

Jon Snyder is a Senior Advisor in Elanco’s External Innovation team, where he seeks to bridge internal and external scientific opportunities with academic, biotech, and large pharma partners.  Prior to joining the External Innovation Team, Jon spent 8 years leading Elanco’s Discovery Biologics and...

Martín Solórzano is a Mexican medical doctor and public health expert with extensive experience leading health programs in Mexico and Spain, focusing on vulnerable populations. A former Mexican Youth Delegate to the United Nations, he has collaborated with international organizations on public...

Nick Spittal is COO of Velocity Clinical Research, the largest global organization of fully-owned clinical research sites. With over two decades in a broad range of roles at global CROs, Nick brings innovative ideas and technology into site operations to fulfill Velocity’s vision of making clinical ...

Nick has 30+ years of major defense acquisition experience leading programs of significant national security interest. He has successfully led multiple programs that required “out-of-the-box” creative strategies and solutions. Some of the investigation of possible solutions led him to DoD’s Other...

Citseko Staples Miller leads FTI Consulting’s Healthcare & Life Sciences Public Affairs team in Washington, DC. Ms. Miller is an experienced public affairs and policy expert who has been engaged in comprehensive, multi-faceted public affairs campaigns at the national, federal, state, and local ...

Ann-Muriel Steff is a dynamic and innovative scientific leader in the field of vaccines and infectious diseases. With a strong background in vaccines R&D across CROs, Pharma and non-profit organizations. Ann-Muriel spent over a decade at GSK Vaccines, in diverse roles, in particular Head of...

Katy Stein is a Virology Scientist with Microbiologics.  She has a Ph.D in Biomedical Sciences from Icahn School of Medicine and Post Doctoral experience from Scripps Research and The Rockefeller University.  Katy has extensive expertise in virology, AAV delivery, and host-microbe...

Katarina Stenklo brings over 20 years of industry experience to her role as Product Manager for the FlexFactory manufacturing platform at Cytiva. She understands the critical importance of having a holistic view of biomolecule manufacturing. With extensive expertise in developing end-to-end...

Julia Stephanus is currently a Partner at Borealis Ventures, a leading venture capital firm specializing in investing in healthcare and the life sciences sectors. With over 35 years of experience in the animal health biotech and pharmaceutical industries, Julia has built and scaled two animal...

Erin Strait is Chief Scientific Officer at Dalan. She has a passion for advancing animal health through innovative vaccine solutions. Prior roles include US Director of Innovation & Development at Ceva Animal Health, as well as US Director of Swine R&D at Merck Animal Health. She holds a...

Walter Straus is Vice President for Clinical Safety & Risk Management at Moderna. After joining Moderna in March 2021, he was charged with building and leading the team responsible for clinical safety and pharmacovigilance for the COVID-19 vaccine program. His current responsibilities include...

Vic Suarez, Colonel (Ret), US Army, MS, PMP, CMRP is the Founder and Principal Growth Partner of Blu Zone Bioscience & Supply Chain Solutions, LLC. Blu Zone Bio assists biotechnology and life science supply chain organizations accelerate growth and expand domestic biomanufacturing through...

Adreana Suenaga has nearly 25 years of experience in clinical research, managing complex global programs, finance, timelines and communication pathways.  She has more than 15 years at Parexel International and is currently leading strategy development for global projects, creating innovative...

Rajinder as CEO-DCVMN International is responsible for providing leadership, shaping strategic vision, governance and overall operational excellence of DCVMN.  Rajinder is serving as committee delegate on GAVI-PPC and has been a member of GAVI’s Vaccine Investment Strategy (VIS) Steering Committee...

Ryo Tanaka studied biological science at the Kyoto Institute of Technology and completed his Ph. D in 2019. Following doctoral study, he started the research and development of Immucise™ Intradermal Injection System at Terumo. Today he is a Sr. Research Scientist in the Pharmaceutical Solutions...

Nigel obtained his BSc in Microbiology and Genetics from University College London (UCL) in 1990 and an MSc in Applied Molecular Biology of Infectious Diseases (1992), PhD in Molecular Parasitology (1999) and DLSHTM (2000) from the London School of Hygiene & Tropical Medicine (LSHTM). After his ...

Sanchia Theron, Executive Director of Client Solutions, is a medical doctor with over 15 years of clinical and research experience, specializing in infectious diseases and vulnerable populations. She gained valuable hands-on experience in clinical medicine and served as an investigator at prominent ...

Dr. Stephen J. Thomas is an Infectious Diseases physician-scientist from SUNY Upstate Medical University in Syracuse, NY, USA. He is a Professor of Medicine and Professor of Microbiology & Immunology. Dr. Thomas currently directs the Upstate Global Health Institute and is the Frank E. Young, MD ...

Douglas Thomson is a Venture Partner at infectious disease investor KAMRA.  He also serves as Chief Executive Officer and was a co-founder at Pneumagen a clinical stage infectious disease business. Prior to co-founding Pneumagen, he led executive teams generating rapid value creation. His...

Thomas Tillett – Cofounder and CEO of MBF Therapeutics, an immunotherapeutics company that has developed and patented an innovative, proprietary T-Max™ DNA vaccine platform to deliver commercial protective vaccines that provide safe, durable, heterologous protection against endemic, emerging and...

​​​​​​Dr. Lucas Tina serves as Board Chairman and Lead Principal Investigator at VIBRI in Kenya, and as a leading Clinical Research Scientist at KEMRI-WRP. He is the Director and a Scientific Advisor for ACE Research, and a Scientific Advisory Expert for FHI Clinical. Dr. Tina earned his Medical...

Gregorio Torres is the head of the Science Department of the World Organisation for Animal Health (WOAH) based in Paris. He contributes to the WOAH’s systems for identifying and implementing science arising from development and review of international standards and other programmes. Dr Torres is...

Laura Treml serves as Senior Vice President, Companion Animal Division, for Phibro Animal Health. Her responsibilities include overseeing sales, management of the companion animal pipeline development, and leading business development efforts for the division. Dr. Treml began her career as a...

Dr. Vianney Tricou is a clinical development and medical affairs professional with expertise in infectious diseases. Holding a PharmD from the University of Lyon and a PhD from the University of Oxford, he has gained extensive experience working in Asia and Africa with leading academic...

Dr. Sean Tucker is the Founder of Vaxart and has served as its Chief Scientific Officer since February 2010.   From March 2004 to February 2010, Sean served as Vice President of Research and Director of Immunology.  He has held numerous scientific and engineering roles at various biotechnology...

 Jennifer has been a digital and decentralized (DCT) solutions subject matter expert since 2015, advising sponsors on how best to leverage decentralized solutions that minimize patient and site burden while supporting inclusive representation amongst diverse communities for global clinical trials.  ...

Isaac is a Senior Analyst at Airfinity, currently working in the respiratory infectious disease vaccines team. Before joining Airfinity, Isaac graduated from the University of Oxford with a degree in Cell & Systems biology, focusing on immunology and genetics. Since joining Airfinity in...

Sander is a biomedical scientist with a focus on poly-nucleotides and nano-particle drugs. He holds a Msc in Biomedical Sciences from the Radboud University Nijmegen and performed his PhD on messenger RNA (mRNA)-based drugs under the supervision of Prof. Brock. Based on this experience, he founded...

Wouter van den Braak, M.Sc., is a Scientist and BD Associate at Intravacc, a leading CDMO for translational vaccinology. With a background in molecular virology he has spent the better part of a decade working in the vaccine industry, developing viral vaccines against several enteroviruses. Using...

Robert van der Put holds both a PhD in conjugate vaccine development and a master’s degree in drug innovation and has over 20 years of experience in the vaccine industry. He is a passionate and driven Director of Business Development at Intravacc, a leading CDMO for translational vaccinology. His...

Tyler is an accomplished senior leader whose primary focus is accelerating global growth strategy, maintaining operational excellence, guiding corporate investments, and building corporate portfolios. Since joining Science 37 in 2021, he has played an instrumental role in developing and executing...

Katie Van Tornhout is the founder of Callie Cares, a not-for-profit organization founded in 2010 that supports parents with hospitalized children and raises awareness about the seriousness of whooping cough (pertussis) and the importance of routine immunizations for pregnant people and children. ...

Roland Ventura holds a PhD in molecular biology and vaccines from the Queen’s University Belfast.  After postdoctoral training at the University of Oxford he worked with Dako A/S in Denmark under a European Commission-funded Marie Curie Transfer of Knowledge Fellowship.  Following this, he became...

Dr. Tonya Villafana is Vice President, Franchise, Medical & Scientific Affairs, Vaccine & Immune Therapies at AstraZeneca. She has dedicated her career to protecting millions of people around the world from the most challenging infectious diseases. Driven by the belief that as viral and...

Felipe Villalobos is a medical doctor graduated from the Universidad Autonoma Metropolitana in Mexico. Currently, he is a primary care researcher at the IDIAP Jordi Gol pin Barcelona, Spain, with a line of research in health promotion and preventive activities. Last five years, he has been...

Ian brings a distinctive blend of expertise in chemistry and physiology, leading to a thesis project focused on drug delivery and the development of polymeric nanoparticles to large animal models during his doctoral studies. Transitioning to industry, Ian spent nearly four years as a Field...

Guoan Wang is currently Director of Process Development. He joined uBriGene from Innoforce Biopharmaceuticals, where, for three years, he built and led process research and development teams for gene therapy products including plasmid DNA, mRNA, viral vectors (AAV and LV) and non-viral vectors...

Peter Wang is the Director of Marketing and Business Development at BioStone Animal Health, where he focuses on bridging scientific innovation with practical solutions to enhance animal health. As a cofounder of BioStone in 2017, Peter has been involved in developing and expanding access to...

Soazic Elise Wang Sonne is an Economist and data scientist with the Health, Nutrition and Population (HNP) unit of the World Bank Group based in Washington, DC. She has been leading immunization financing analytical work in Lower Middle-Income Country (LMIC) countries in the Africa...

Kelly Warfield, PhD, joined the Sabin Vaccine Institute as its President of Research & Development in August 2024. In this role, Kelly collaborates with executive team members, cross-functional leaders, and the Board of Trustees to drive Sabin’s strategic vision, manage and grow the R&D...

Kerri Weingard is a founding partner and the Global Chief Operating Officer at Verified Clinical Trials (VCT), the world’s largest global research subject database focused on reducing dual enrollment and preventing protocol violations in clinical trials. With a deep commitment to enhancing patient...

​​​​​​​David Weiss is the Director of Corporate Development at Telesis Bio where he is focused on bringing cutting edge synthetic biology technologies, such as the Gibson SOLA Platform, to the market to revolutionize the way in which researchers are able to achieve their development goals. With...

MAJ Wellington is the director of the Walter Reed Army Institute of Research Clinical Trials Center, where he is responsible for all operations, personnel management, and financial planning of the largest clinical trials center in the Department of Defense (DoD) with annual budget of over...

Medical doctor with a master’s degree in Epidemiology, both obtained from the National University of San Marcos, Lima, Perú. Has extensive experience in the surveillance and control of vaccine-preventable and communicable diseases; monitoring and evaluation of public health programs, with a focus...

I obtained my PhD in synthetic organic chemistry at the University of Cape Town before starting at The Biovac Institute, a vaccine manufacturing and distribution company based in Cape Town, as a Senior Product Development Scientist. When first starting at Biovac, I was responsible for the...

Allison N. Winnike, J.D., serves as Director, Western Region, overseeing the Region’s strategic and sustainability planning, day-to-day operations, legal technical assistance, outreach efforts, and product development activities. Allison has an adjunct professor academic appointment at the UTHealth ...

Andrew Wong is a seasoned leader in biotech, vaccine development, and business management. As Senior Advisor to the Board of Directors at Walvax, he has significantly advanced the company’s global operations. Previously, he served as General Manager at Shanghai Wotai Biotechnology, leading a team...

TSW is a Professor of Biomanufacturing at the School of Chemical, Materials, and Biological Engineering (CMBE), University of Sheffieldukse. He leads the £7.6M UK-South East Asia Vaccine Manufacturing Research Hub, supported by the UK’s Department of Health and Social Care (DHSC) and the...

Dr. Sander Wuyts is the founder and CEO of ImmuneWatch.  His mission is to help researchers find the specificity of their T-cell receptors. This is useful for clinical-stage biotech and pharma companies as well as academics who use T-cell receptor sequencing as a way to evaluate the efficacy of...